Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Longley, Rhea J ^a,c,d,e   Salman, Ahmed M ^a,b   Cottingham, Matthew G ^a   Ewer, Katie ^a   Janse, Chris J ^b   Khan, Shahid M ^b   Spencer, Alexandra J ^a   Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; LIVER STAGE-SPECIFIC ANTIGEN, PLASMODIUM; MALARIA VACCINE; PARASITE ANTIGEN;

ANIMAL; CD8+ T LYMPHOCYTE; GENE VECTOR; HUMAN; IMMUNOLOGY; LIVER; MALARIA, FALCIPARUM; MOUSE; PARASITOLOGY; PATHOGENICITY; PLASMODIUM FALCIPARUM; VACCINATION;

ANIMALS; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LIVER; MALARIA VACCINES; MALARIA, FALCIPARUM; MICE; PLASMODIUM FALCIPARUM; VACCINATION;

EID: 84946809896     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11820     Document Type: Article

References (55)

1. Hoffman, S. L. et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. The Journal of infectious diseases 185, 1155-1164, doi: 10.1086/339409 (2002).
2. Seder, R. A. et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science (New York, N.Y.) 341, 1359-1365, doi: 10.1126/science.1241800 (2013).
3. Mellouk, S., Lunel, F., Sedegah, M., Beaudoin, R. L. & Druilhe, P. Protection against malaria induced by irradiated sporozoites. Lancet 335, 721 (1990).
4. Schofield, L. et al. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664-666, doi: 10.1038/330664a0 (1987).
5. Weiss, W. R. & Jiang, C. G. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PloS one 7, e31247, doi: 10.1371/journal.pone.0031247 (2012).
6. Agnandji, S. T. et al. Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites. PLoS medicine 11, e1001685, doi: 10.1371/journal.pmed.1001685 (2014).
7. Ewer, K. J. et al. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nature communications 4, 2836, doi: 10.1038/ncomms3836 (2013).
8. Doolan, D. L. et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proceedings of the National Academy of Sciences of the United States of America 100, 9952-9957, doi: 10.1073/pnas.1633254100 (2003).
9. Gruner, A. C. et al. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PloS one 2, e1371, doi: 10.1371/journal.pone.0001371 (2007).
10. Kumar, K. A. et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444, 937-940, doi: 10.1038/nature05361 (2006).
11. Mauduit, M. et al. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infection and immunity 78, 2182-2188, doi: 10.1128/iai.01415-09 (2010).
12. Cockburn, I. Chimeric parasites as tools to study Plasmodium immunology and assess malaria vaccines. Methods in molecular biology (Clifton, N.J.) 923, 465-479, doi: 10.1007/978-1-62703-026-7-32 (2013).
13. Cummings, J. F. et al. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine 28, 5135-5144, doi: 10.1016/j.vaccine.2009.08.046 (2010).
14. Sauzet, J. P., Perlaza, B. L., Brahimi, K., Daubersies, P. & Druilhe, P. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge. Infection and immunity 69, 1202-1206, doi: 10.1128/iai.69.2.1202-1206.2001 (2001).
15. Bergmann-Leitner, E. S. et al. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits crossspecies protection against heterologous challenge with Plasmodium berghei. PloS one 5, e12294, doi: 10.1371/journal.pone.0012294 (2010).
16. Limbach, K. et al. Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates. Malaria journal 10, 65, doi: 10.1186/1475-2875-10-65 (2011).
17. Siau, A. et al. Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection. PLoS pathogens 4, e1000121, doi: 10.1371/journal.ppat.1000121 (2008).
18. Vignali, M. et al. Interaction of an atypical Plasmodium falciparum ETRAMP with human apolipoproteins. Malaria journal 7, 211, doi: 10.1186/1475-2875-7-211 (2008).
19. Burbelo, P. D., Ching, K. H., Klimavicz, C. M. & Iadarola, M. J. Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). Journal of visualized experiments: JoVE, doi: 10.3791/1549 (2009).
20. Spencer, A. J. et al. Enhanced Vaccine-Induced CD8+ T Cell Responses to Malaria Antigen ME-TRAP by Fusion to MHC Class II Invariant Chain. PloS one 9, e100538, doi: 10.1371/journal.pone.0100538 (2014).
21. Mueller, A. K. et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proceedings of the National Academy of Sciences of the United States of America 102, 3022-3027, doi: 10.1073/pnas.0408442102 (2005).
22. Krzych, U., Dalai, S., Zarling, S. & Pichugin, A. Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria. Frontiers in immunology 3, 370, doi: 10.3389/fimmu.2012.00370 (2012).
23. Reyes-Sandoval, A. et al. CD8+ T effector memory cells protect against liver-stage malaria. Journal of immunology (Baltimore, Md.: 1950) 187, 1347-1357, doi: 10.4049/jimmunol.1100302 (2011).
24. Brando, C. et al. Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A. Infection and immunity 75, 838-845, doi: 10.1128/iai.01075-06 (2007).
25. Ferraro, B. et al. Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA. Infection and immunity 81, 3709-3720, doi: 10.1128/iai.00180-13 (2013).
26. Yewdell, J. W. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25, 533-543, doi: 10.1016/j.immuni.2006.09.005 (2006).
27. Hollingdale, M. R. et al. Non-CS pre-erythrocytic protective antigens. Immunology letters 25, 71-76 (1990).
28. Montagna, G. N. et al. Antigen Export during Liver Infection of the Malaria Parasite Augments Protective Immunity. mBio 5, doi: 10.1128/mBio.01321-14 (2014).
29. Spielmann, T., Montagna, G. N., Hecht, L. & Matuschewski, K. Molecular make-up of the Plasmodium parasitophorous vacuolar membrane. International journal of medical microbiology: IJMM 302, 179-186, doi: 10.1016/j.ijmm.2012.07.011 (2012).
30. Jenne, C. N. & Kubes, P. Immune surveillance by the liver. Nature immunology 14, 996-1006, doi: 10.1038/ni.2691 (2013).
31. Berenzon, D. et al. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. Journal of immunology (Baltimore, Md. : 1950) 171, 2024-2034 (2003).
32. Krzych, U. et al. The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites. Immunological reviews 174, 123-134 (2000).
33. Nganou-Makamdop, K., van Gemert, G. J., Arens, T., Hermsen, C. C. & Sauerwein, R. W. Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNgamma responses of hepatic CD8+ memory T cells. PloS one 7, e36508, doi: 10.1371/journal.pone.0036508 (2012).
34. Reyes-Sandoval, A. et al. Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses. Infection and immunity 78, 145-153, doi: 10.1128/iai.00740-09 (2010).
35. Teirlinck, A. C. et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS pathogens 7, e1002389, doi: 10.1371/journal.ppat.1002389 (2011).
36. Fidock, D. A. et al. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. Journal of immunology (Baltimore, Md. : 1950) 153, 190-204 (1994).
37. Yang, C. et al. Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates. Molecular and biochemical parasitology 71, 291-294 (1995).
38. Hill, A. V. et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434-439, doi: 10.1038/360434a0 (1992).
39. John, C. C. et al. Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya. Infection and immunity 68, 5198-5204 (2000).
40. Krzych, U. et al. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. Journal of immunology (Baltimore, Md. : 1950) 155, 4072-4077 (1995).
41. Kurtis, J. D., Lanar, D. E., Opollo, M. & Duffy, P. E. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. Infection and immunity 67, 3424-3429 (1999).
42. Luty, A. J. et al. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. The Journal of infectious diseases 179, 980-988, doi: 10.1086/314689 (1999).
43. Luty, A. J. et al. Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria. European cytokine network 9, 639-646 (1998).
44. Migot-Nabias, F. et al. Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 557-562 (2000).
45. Mikolajczak, S. A. et al. Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites. Cellular microbiology 13, 1250-1260, doi: 10.1111/j.1462-5822.2011.01617.x (2011).
46. Luo, M. et al. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Journal of virological methods 154, 121-127, doi: 10.1016/j.jviromet.2008.08.011 (2008).
47. Cottingham, M. G. et al. Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors. Biotechnology and bioengineering 109, 719-728, doi: 10.1002/bit.24342 (2012).
48. Douglas, A. D. et al. Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1. Vaccine 28, 7167-7178, doi: 10.1016/j.vaccine.2010.08.068 (2010).
49. Lin, J. W. et al. A novel 'gene insertion/marker out' (GIMO) method for transgene expression and gene complementation in rodent malaria parasites. PloS one 6, e29289, doi: 10.1371/journal.pone.0029289 (2011).
50. Janse, C. J., Ramesar, J. & Waters, A. P. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nature protocols 1, 346-356, doi: 10.1038/nprot.2006.53 (2006).
51. Ponnudurai, T., Leeuwenberg, A. D. & Meuwissen, J. H. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Tropical and geographical medicine 33, 50-54 (1981).
52. Janse, C. J. et al. High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Molecular and biochemical parasitology 145, 60-70, doi: 10.1016/j.molbiopara.2005.09.007 (2006).
53. Orr, R. Y., Philip, N. & Waters, A. P. Improved negative selection protocol for Plasmodium berghei in the rodent malarial model. Malaria journal 11, 103, doi: 10.1186/1475-2875-11-103 (2012).
54. Menard, R. & Janse, C. Gene targeting in malaria parasites. Methods (San Diego, Calif.) 13, 148-157, doi: 10.1006/meth.1997.0507 (1997).
55. Reyes-Sandoval, A. et al. Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity. Molecular therapy: the journal of the American Society of Gene Therapy 20, 1633-1647, doi: 10.1038/mt.2012.25 (2012).